Abstract

ObjectiveBiochemical assessment is recommended for patients prior to initiating and following a ketogenic diet (KD). There is no published literature regarding current practice in the UK and Ireland. We aimed to explore practice in comparison with international guidelines, determine approximate costs of biochemical testing in KD patients across the UK and Ireland, and promote greater consistency in KD services nationally.MethodsA survey was designed to determine the biochemical tests requested for patients at baseline, 3, 6, 12, 18, and 24 months + on KD. The survey was circulated to 39 centers across the UK and Ireland.ResultsSixteen centers completed the survey. Full blood count, electrolytes, calcium, liver function tests (LFTs), lipid profile, and vitamin D were requested at all centers at baseline, in keeping with international guidelines. Bicarbonate, total protein, and urinalysis were less consistently requested. Magnesium and zinc were requested by all centers, despite not being specifically recommended for pre‐diet evaluation in guidelines. Urea and electrolyte profiles and some LFTs were consistently requested at follow‐up, in accordance with guidelines. Other LFTs and renal tests, full blood count, lipid profile, acylcarnitine profile, selenium, vitamin D, and urinalysis were less consistently requested at follow‐up. The mean costs of the lowest and highest number of tests requested at baseline in our participating centers were £167.54 and £501.93; the mean costs of the lowest and highest number of tests requested at 3‐month follow‐up were £19.17 and £450.06.SignificanceBiochemical monitoring of KD patients varies widely across the UK and Ireland and does not fully correspond to international best practice guidelines. With an ongoing drive for cost‐effectiveness within health care, further work is needed to streamline practice while ensuring patient safety.

Highlights

  • Ketogenic diets (KDs) are high-fat, low-carbohydrate, moderate protein diets used as a treatment option for drug-resistant epilepsy

  • KDs are inappropriate for some individuals, for example, with primary carnitine deficiencies and β-oxidation defects and screening biochemical tests to rule out such disorders are a crucial part of pre-diet assessment

  • A survey was designed by the Ketogenic Dietitians Research Network (KDRN) to identify biochemical tests requested in patients commencing and following a KD for epilepsy and metabolic disorders in centres in the UK and Ireland

Read more

Summary

Introduction

Ketogenic diets (KDs) are high-fat, low-carbohydrate, moderate protein diets used as a treatment option for drug-resistant epilepsy. KDs are inappropriate for some individuals, for example, with primary carnitine deficiencies and β-oxidation defects and screening biochemical tests to rule out such disorders are a crucial part of pre-diet assessment. International consensus guidelines regarding optimal care of paediatric patients on KD therapies have been recently updated, including which biochemical tests (blood and urine) should be completed prior to diet initiation and during the treatment period[6]. These follow on from KD care guidelines for resource-limited countries published in 2015, including required and desired biochemical monitoring[7]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call